TP53 and neoplasm: While mutations in TP53, which are often missense mutations, result in the abrogation of wild-type (WT) p53-mediated tumor suppressive functions, some mutations have been reported to endow mutant p53 proteins with novel oncogenic properties termed gain-of-function (GOF) activities [12,13,14,15].